Efficacy and tolerability of lovastatin in 459 African-Americans with hypercholesterolemia

American Journal of Cardiology

Volumn 78, Issue 4, 1996, Pages 420-424

  Prisant, L Michael ^a   Downton, Maria ^b   Watkins, Laurence O ^b   Schnaper, Harold ^b   Bradford, Reagan H ^b   Chremos, Athanassios N ^b   Langendörfer, Alexandra ^b  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CREATINE KINASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEGRO; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0030586913     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00330-X     Document Type: Article

References (14)

1. 1. National Cholesterol Education Program Expert Panel. Second Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High blood cholesterol in Adults. JAMA 1993:269:3015-3023.
2. 2. Sempos CT, Cleeman JI, Carroll MD, Johnson CL, Bachorik PS, Gordon DJ, Burt VL, Briefel RR, Brown CD, Lippel K, Rifkind BM. Prevalence of high blood cholesterol among US adultws. An update based on guidelines from the second report of the National Cholesterol Education Program Adult Treatment Panel. JAMA 1993;269:2009-3014.
3. 3. Grundy SM. HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N Engl J Med 1988;319:24-33.
4. 4. Bradford RH, Shear CL, Chremos AN, Dujovne C, Franklin FA, Hesney M, Higgins J, Langendörfer A, Pool JL, Schnaper H, Stephenson WP. Expanded Clinical Evaluation of Lovastatin (EXCEL) Study: design and patient characteristics of a double-blind, placebo-controlled study in patients with moderate hypercholesteremia. Am J Cardiol 1990;66:44B-55B.
5. 5. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 1972;18:499-502.
6. 6. Bradford RH, Shear CL, Chremos AN, Dujovne C, Downton M, Franklin FA, Gould AL, Hesney M, Higgins J, Hurley DP, Langendörfer A, Nash DT, Pool JL, Schnaper H. Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia. Arch Intern Med 1991;151:43-49.
7. 7. Koch G, Edwards S. Clinical efficacy trials with categorical data. In: Peace CE, ed: Biopharmaceutical Statistics for Drug Development. New York: Marcel Dekker, 1988:403-457.
8. 8. Cardiovascular disease and stroke in African-Americans and other minorities in the United States. A statement for health professionals. Circulation 1991;83:1462-1480.
9. 9. Curry CL, Oliver J, Mumtaz FB. Coronary artery disease in blacks: risk factors. Am Heart J 1984;108:653-657.
10. 10. Gillum RF. Coronary heart disease in black populations. II. Risk factors. Am Heart J 1982;104:852-864.
11. 11. Sempos S, Fulwood R, Haines C, Carroll M, ANda R, Williamson DF, Remington P, Cleeman J. The prevalence of high blood cholesterolemia levels among adults in the United States. JAMA 1989;262:45-52.
12. 12. Shear CL, Franklin FA, Stinnett S, Hurley DP, Bradford RH, Chremos AN, Nash DT, Langendörfer A. The Expanded Clinical Evaluation of Lovastatin (EXCEL) Study results: the effect of patient characteristics on lovastatin-induced changes in plasma concentration of lipids and lipoproteins. Circulation 1992;85(4):1293-1303.
13. 13. Watkins LO, Neaton JD, Kuller LH. Racial differences in high-density lipoprotein cholesterol and coronary heart disease incidence in the usual-care group of the multiple risk factor intervention trial. Am J Cardiol 1986;57:538-545.
14. 14. Wong ET, Cobb C, Umehara MK, Wolff GA, Haywood LJ, Greenberg T, Shaw ST Jr. Heterogeneity of serum creatine kinase activity among racial and gender groups of the population. Am J Clin Pathol 1983;79:582-586.